Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial by Trněný, Marek, Prof, Lamy, Thierry, Prof, Walewski, Jan, Prof, Belada, David, MD, Mayer, Jiri, MD, Radford, John, Prof, Jurczak, Wojciech, MD, Morschhauser, Franck, Prof, Alexeeva, Julia, MD, Rule, Simon, Prof, Afanasyev, Boris, Prof, Kaplanov, Kamil, MD, Thyss, Antoine, Prof, Kuzmin, Alexej, MD, Voloshin, Sergey, MD, Kuliczkowski, Kazimierz, Prof, Giza, Agnieszka, MD, Milpied, Noel, Prof, Stelitano, Caterina, MD, Marks, Reinhard, MD, Trümper, Lorenz, Prof, Biyukov, Tsvetan, MD, Patturajan, Meera, PhD, Bravo, Marie-Laure Casadebaig, MSc, Arcaini, Luca, Prof

Get full text

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years... by Harousseau, Jean-Luc, Martinelli, Giovanni, Jedrzejczak, Wieslaw W., Brandwein, Joseph M., Bordessoule, Dominique, Masszi, Tamas, Ossenkoppele, Gert J., Alexeeva, Julia A., Beutel, Gernot, Maertens, Johan, Vidriales, Maria-Belen, Dombret, Hervé, Thomas, Xavier, Burnett, Alan K., Robak, Tadeusz, Khuageva, Nuriet K., Golenkov, Anatoly K., Tothova, Elena, Mollgard, Lars, Park, Youn C., Bessems, Annick, De Porre, Peter, Howes, Angela J.

Get full text

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience by Chitanava, Tamara, Matvienko, Iuliia, Shuvaev, Vasily, Voloshin, Sergey, Martynkevich, Irina, Vlasova, Yulia, Efremova, Elizaveta, Mileeva, Ekaterina, Pirkhalo, Anna, Makarova, Taiana, Vlasik, Roman, Karyagina, Elena, Il Ina, Natalia, Medvedeva, Nadezhda, Dorofeeva, Natalia, Shneider, Tatiana, Siordiya, Nadia, Kulemina, Olga, Sbityakova, Evgenia, Lazorko, Natalia, Alexeeva, Julia, Motorin, Dmitrii, Morozova, Elena, Lomaia, Elza

Get full text

Rapid Efficacy of Gemtuzumab Ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure by Zaytsev, Daniil, Girshova, Larisa, Ivanov, Vladimir, Budaeva, Irina, Motorin, Dmitri, Badaev, Renat, Mirolubova, Julia, Grobovenko, Evgeni, Chitanava, Tamara, Zaykova, Ekaterina, Alexeeva, Julia, Zaritskey, Andrey

Get full text

POSTER: AML-385 Clinical Impact of CD200 Expression on Outcome of Acute Myeloid Leukemia (AML) by Girshova, Larisa, Shatilova, Aleksina, Budaeva, Irina, Matvienko, Yulia, Levchuk, Ksenia, Mirolubova, Julia, Alexeeva, Julia, Lomaia, Elza

Get full text

AML-385 Clinical Impact of CD200 Expression on Outcome of Acute Myeloid Leukemia (AML) by Girshova, Larisa, Shatilova, Aleksina, Budaeva, Irina, Matvienko, Yulia, Levchuk, Ksenia, Mirolubova, Julia, Alexeeva, Julia, Lomaia, Elza

Get full text

BCR-ABL1+ AML De Novo and CBF-Leukemia at Relapse: Game of Clones by Kulemina, Olga, Siordia, Nadia, Bogdanov, Konstantin, Alexeeva, Julia, Girshova, Larisa, Lomaia, Elza, Zaritskey, Andrey

Get full text

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in tra... by Robak, Tadeusz, Jin, Jie, Pylypenko, Halyna, Verhoef, Gregor, Drach, Johannes, Pereira, Juliana, Tumyan, Gayane, Okamoto, Rumiko, Appiani, Carlos, Cavalli, Franco, Sheliga, Adriana, Teixeira, Adriana, Tomita, Akihiro, Rocafiguera, Albert Oriol, Suvorov, Alexander, Kuzmin, Alexy, Mezlini, Amel, Bosly, Andre, Van De Velde, Ann, Illes, Árpád, Garichochea, Bernardo, Gabarrón, Caballero, Cao, Carmen, Souza, Carmino, Farber, Charles, Burcoveanu, Cristina Ileana, Cebotaru, Cristina Ligia, Truica, Cristina-Ligia, Maruyama, Dai, Belada, David, Udovitsa, Dmitry, Dolores, Morra, Enrica, Späth-Schwalbe, Ernst, Gonzalez-Barca, Eva, Osmanov, Evgenii, Heß, Georg, Manikhas, Georgii, Babu, Govind, Rekhtman, Grigoriy, Rossi, Guiseppe, Marques, Herlander, Bumbea, Horia, Huang, Huiqiang, Choi, Ilseung, Bulavina, Irina, Lysenko, Irina, Avivi, Irit, Kryachok, Iryna, Zaucha, Jan Maciej, Novak, Jan, Díaz, Joaquín, Demeter, Judit, Zhu, Jun, Vilchevskaya, Kateryna, Tobinai, Kensei, Ando, Kiyoshi, Abdulkadryrov, Kudrat, Shih, Lee-Yung, Gumus, Mahmut, De Wit, Maike, Capra, Marcelo, Golubeva, Marina, Crump, Michael, Baccarani, Michele, Egyed, Miklós, Udvardy, Miklos, Kurosawa, Mitsutoshi, Uike, Naokuni, Khuageva, Nuriet, Gladkov, Oleg, Samoilova, Olga, Serduk, Olga, Santi, Patricia, Stoia, Razvan, Gressin, Remy, Arranz, Reyes, Greil, Richard, Cancelado, Sergio, Nair, Sreejith, Le Gouill, Steven, Van Steenweghen, Steven, Scheider, Tatiana, Shimoyama, Tatsu, Kinoshita, Tomohiro, Pavlov, Viacheslav, Phooshkooru, Vijay Rao, Lima, Vladimir, Merkulov, Vladimir, Nawarawong, Weerasak, Hong, Xiaonan, Ke, Xiaoyan, Terui, Yasuhito, Tee Goh, Yeow, Dunaev, Yuri, Lorie, Yurii, Wang, Zhao, Shen, Zhixiang, Borbenyi, Zita, Masliak, Zvenyslava

Get full text

Thermodynamics and amorphization of the copper–zirconium alloys by Zaitsev, Alexander I., Zaitseva, Natal'ya E., Alexeeva, Julia P., Dunaev, Sergey F., Nechaev, Yurii S.

Get full text

Comparative Characteristics of the Effectiveness of Tyrosine Kinase Inhibitors Vs Allogeneic Hematopoietic Stem Cell Transplantation in the Chronic Phase of Chronic Myeloid Leukemi... by Lomaia, Elza, Chitanava, Tamara, Vlasova, Yulia, Motorin, Dmitry, Voloshin, Sergey, Zammoeva, Darina, Badaev, Renat, Matvienko, Yulia, Efremova, Elizaveta, Mileeva, Ekaterina, Siordia, Nadia, Kulemina, Olga, Sbityakova, Eugenia, Lazorko, Natalia, Alexeeva, Julia, Martynkevich, Irina, Karyagina, Elena, Ilyina, Natalia, Medvedeva, Nadezhda, Dorofeeva, Natalia, Shneider, Tatiana, Stepanova, Svetlana, Shuvaev, Vasily, Morozova, Elena

Get full text

Poster: AML-275: Non-Intensive Chemotherapy in Elderly: Low-Efficacy ICT is Too Toxic and Targeted Therapy is Optimal by Girshova, Larisa, Budaeva, Irina, Zaytsev, Daniil, Shatilova, Alexina, Rogovaia, Julia, Bogdanov, Konstantin, Nikulina, Tatjana, Mirolubova, Julia, Ivanov, Vladimir, Osipov, Iurii, Alexeeva, Julia, Zaritskey, Andrey

Get full text

AML-275: Non-Intensive Chemotherapy in Elderly: Low-Efficacy ICT is Too Toxic and Targeted Therapy is Optimal by Girshova, Larisa, Budaeva, Irina, Zaytsev, Daniil, Shatilova, Alexina, Rogovaia, Julia, Bogdanov, Konstantin, Nikulina, Tatjana, Mirolubova, Julia, Ivanov, Vladimir, Osipov, Iurii, Alexeeva, Julia, Zaritskey, Andrey

Get full text

Hematopoietic Recovery After Haploidentical SCT, Comparison with Results of Matched Related SCT (MRD-SCT) by Zammoeva, Darina, Badaev, Renat, Babenetskaya, Diana, Il’ina, Natalia, Alexeeva, Julia, Zaritskey, Andrey, Motorin, Dmitriy

Get full text

AML-291: MRD Level After Induction Therapy in NPM1-Mutated Patients Identifies Those at High Risk of Relapse and Defines Indications for HSCT by Girshova, Larisa, Budaeva, Irina, Zaytsev, Daniil, Rogovaia, Julia, Shatilova, Alexina, Badaev, Renat, Bogdanov, Konstantin, Nikulina, Tatjana, Mirolubova, Julia, Motorin, Dmitry, Petukhov, Alexey, Alexeeva, Julia, Zaritskey, Andrey

Get full text

Prospective subgroup analyses of the randomized MCL‐002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma by Arcaini, Luca, Lamy, Thierry, Walewski, Jan, Belada, David, Mayer, Jiri, Radford, John, Jurczak, Wojciech, Morschhauser, Franck, Alexeeva, Julia, Rule, Simon, Cabeçadas, José, Campo, Elias, Pileri, Stefano A., Biyukov, Tsvetan, Patturajan, Meera, Casadebaig Bravo, Marie‐Laure, Trnĕný, Marek

Get full text

Aza Maintenance After Consolidation Increase RFS in Mrdve+ Low Risk AML Patients by Girshova, Larisa, Budaeva, Irina, Zaicev, Daniil, Ovsiannikova, Ekaterina, Badaev, Renat, Nikulina, Tatjana, Bogdanov, Konstantin, Mirolubova, Julia, Motorin, Dmitrij, Alexeeva, Julia, Zaritskey, Andrey

Get full text

Phase II Randomized, Multicenter Study of Lenalidomide Vs Best Investigator’s Choice in Relapsed/Refractory Mantle Cell Lymphoma: Results of the MCL-002 (SPRINT) Study by Trneny, Marek, Lamy, Thierry, Walewski, Jan, Jurczak, Wojciech, Belada, David, Mayer, Jiri, Radford, John, Alexeeva, Julia, Osmanov, Dzhelil, Biyukov, Tsvetan, Patturajan, Meera, Casadebaig Bravo, Marie-Laure, Arcaini, Luca

Get full text

Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup... by Trneny, Marek, Lamy, Thierry, Walewski, Jan, Belada, David, Mayer, Jiri, Radford, John A, Jurczak, Wojciech, Morschhauser, Franck, Alexeeva, Julia, Rule, Simon A., Afanasyev, Boris V, Kaplanov, Kamil, Thyss, Antoine, Kuzmin, Alexej, Voloshin, Sergey, Kuliczkowski, Kazimierz, Giza, Agnieszka, Milpied, Noel, Stelitano, Caterina, Marks, Reinhard, Trümper, Lorenz, Biyukov, Tsvetan, Barnett, Evelyn, Casadebaig Bravo, Marie-Laure, Arcaini, Luca

Get full text

Efficacy and Safety of Single-Agent Ibrutinib in Patients with Mantle Cell Lymphoma Who Progressed after Bortezomib Therapy by Wang, Michael, Goy, Andre, Martin, Peter, Ramchandren, Rod, Alexeeva, Julia, Popat, Rakesh, Avivi, Irit, Advani, Ranjana, Le Gouill, Steven, Horowitz, Netanel, Yuan, Zhilong, Kranenburg, Britte, Rizo, Aleksandra, Zhuang, Sen Hong, Deraedt, William, Rule, Simon

Get full text

Bortezomib (Btz) Dose Intensity Is the Strongest Predictor for Overall Survival (OS) in Mantle Cell Lymphoma (MCL) Patients (Pts) Not Considered for Transplantation, Receiving Fron... by Robak, Tadeusz, Huang, Huiqiang, Jin, Jie, Zhu, Jun, Liu, Ting, Samoilova, Olga S, Pylypenko, Halyna, Verhoef, Gregor, Siritanaratkul, Noppadol, Osmanov, Evgenii A, Alexeeva, Julia, Pereira, Juliana, Mayer, Jiri, Hong, Xiaonan, Maeda, Yoshiharu, Pei, Lixia, Rooney, Brendan, van de Velde, Helgi, Cavalli, Franco

Get full text